Select all on this page
|
1
|
The effect of pure compound AG in a transgenic mice model of Alzheimer’s disease
-
/
Department of Life Science
/106/ Master
-
Author:
Song, Yan-Qing
Advisor:
Lin, Yenshou
-
There were approximately 48 million people developing Alzheimer’s disease (AD), one of the most c...
-
Clicks: 163
Downloads: 4
|
2
|
Dysfunction of TBP contributes to the pathogenesis of tauopathy
-
/
Department of Life Science
/100/ Master
-
Author:
Hsiang-Yu Wang
Advisor:
Su, Ming-Tsan
-
Previous studies found that the TATA box-binding protein (TBP) is sequestered by tau-mediated neu...
-
Clicks: 241
Downloads: 1
|
3
|
Preventive mechanism of caffeic acid against Alzheimer's disease in hyperinsulinemic rats
|
4
|
Functional Study of twins, the Drosophila PP2A B Subunit and it’s Interaction with Tau
This full text is not authorized to be published.
-
/
Department of Life Science
/98/ Doctor
-
Author:
Po-An Yeh
Advisor:
Su, Ming-Tsan
-
Misregulated PR55Bβ, a B regulatory subunit of protein phosphotase 2A (PP2A), has long been docum...
-
Clicks: 224
Downloads: 0
|
5
|
Using ΔK280 TauRD folding reporter cells to screen TRKB agonists as Alzheimer’s disease treatment strategy
Public on Internet date: 2027/09/27
|
6
|
The effect of Baicalein derivatives on cortical neurons and on an Alzheimer’s disease mouse model
Public on Internet date: 2029/04/10
|
7
|
The Difference between Alzheimer’s Disease and Healthy Elders’ Humor Comprehension: Executive Functions and Theory of Mind as Mediators
|
8
|
To investigate the mechanism of Rutin on improving Aβ oligomers-induced neuronal pathophysiology
Public on Internet date: 2029/12/20
|
9
|
Pure compounds TR and AG within Chinese herbal medicines mediate glutamate receptors to attenuate Aβ-induced neuronal pathophysiology.
-
/
Department of Life Science
/104/ Master
-
Author:
Kuo, Li-Chen
Advisor:
Lin, Yenshou
-
Alzheimer’s disease (AD), a progressive neurodegenerative disease leads to memory impairment and ...
-
Clicks: 275
Downloads: 1
|
10
|
The development and mechanism of PN derivatives as therapeutic drugs for Alzheimer’s disease
Public on Internet date: 2028/07/20
|